Latest filing published 22 Dec 2024 for InMed Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
Shane Aaron Johnson: trading record in brief
Shane Aaron Johnson discloses dealings in InMed Pharmaceuticals Inc. to SEC (Form 4). Between 2 November 2021 and 14 November 2024, the trades on record add up to 5 filings.
The open-market record is one-sided, with 2 purchases worth €12k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 22 December 2024, reports a transaction in InMed Pharmaceuticals Inc. The clock since the last published purchase (30 December 2021) now reads 1,776 days. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Shane Aaron Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,574 sharesCommon SharesTSXSEDI:4423068
- 292,411 sharesCommon SharesTSXSEDI:4017835
- 8,093 shares@ CA$1.3266100.0% of flowCommon SharesTSXSEDI:3857275Canonical exit: 30 Mar 2022 (T+90)
- 5,000 shares@ CA$1.36939.2% of flowCommon SharesTSXSEDI:3831505Canonical exit: 13 Feb 2022 (T+90)
- Common SharesTSXSEDI:3824519
5 of 5 declarations
